Cognition Support

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Panax ginseng, Quantity: 70.83 mg (Equivalent: Panax ginseng, Qty 212.5 mg; Equivalent: ginsenosides Rg1- Re- Rf- Rg2- Rb1- Rb2- Rc- Rd (of Panax ginseng), Qty 4.25 mg); alpha lipoic acid, Quantity: 300 mg; Ginkgo biloba, Quantity: 60 mg; Bacopa monnieri, Quantity: 200 mg

Available from:

FIT-BioCeuticals Pty Ltd

INN (International Name):

alpha lipoic acid,Bacopa monnieri,Ginkgo biloba,Panax ginseng

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: Carnauba Wax; colloidal anhydrous silica; croscarmellose sodium; hypromellose; crospovidone; macrogol 400; chlorophyllin-copper complex; magnesium stearate; povidone; microcrystalline cellulose; calcium hydrogen phosphate dihydrate

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support energy production ; Maintain/support physical endurance/capacity/stamina ; Relieve weariness/tiredness/fatigue/feeling of weakness ; Maintain/support healthy blood circulation ; Maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; Maintain/support cognitive function/mental function ; Maintain/support learning and information processing ; Maintain/support memory/mental recall

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2014-11-05